Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Meta-analysis of Data from Clinical Trials (207263)

Study identification

• EU PAS number:
  EUPAS16324
• Study ID:
  42134
• Official title and acronym:
  Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Meta-analysis of Data from Clinical Trials (207263)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Finalised

Research institutions and networks

Institutions

ViiV Healthcare

Study timelines

Date when funding contract was signed

Planned: 04/11/2016

Actual: 09/11/2016

Study start date

Planned: 01/12/2016

Actual: 30/11/2016

Data analysis start date

Planned: 01/12/2016

Actual: 30/11/2016

Date of final study report

Planned: 30/04/2017

Actual: 06/07/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ViiV Healthcare

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable